Who owns Spero Therapeutics Inc?
- Ticker: SPRO
- CUSIP Number: 84833t103
Tip: Access positions for across all investors
Analyze quarterly positions in Spero Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Spero Therapeutics stock
Who bought or sold Spero Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Pfizer | 2.4M | $5.5M | 0% | Mar 2026 |
|
| Vanguard Capital Management | 1.8M | $4.2M | 100% | Mar 2026 |
|
| Renaissance Technologies | 1.2M | $2.8M | -7% | Mar 2026 |
|
| Alphabet | 890k | $2.1M | 0% | Mar 2026 |
|
| Two Sigma Investments | 886k | $2.1M | 138% | Mar 2026 |
|
| Geode Capital Management | 520k | $1.2M | -2% | Mar 2026 |
|
| BlackRock | 433k | $1.0M | 0% | Mar 2026 |
|
| Citadel Advisors | 426k | $996k | -10% | Mar 2026 |
|
| Frigate Ventures | 422k | $987k | -32% | Mar 2026 |
|
| Susquehanna International | 382k | $893k | 30% | Mar 2026 |
|
| GSA Capital Partners | 278k | $651k | 56% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 264k | $618k | 100% | Mar 2026 |
|
| State Street Corporation | 215k | $503k | 2% | Mar 2026 |
|
| Ionic Capital Management | 196k | $459k | 0% | Mar 2026 |
|
| Squarepoint Ops | 194k | $455k | 63% | Mar 2026 |
|
| Jane Street | 183k | $427k | -7% | Mar 2026 |
|
| Marshall Wace | 157k | $368k | 100% | Mar 2026 |
|
| Northern Trust | 121k | $283k | 0% | Mar 2026 |
|
| Bridgeway Capital Management | 115k | $269k | 0% | Mar 2026 |
|
| Shay Capital | 70k | $165k | 100% | Mar 2026 |
|
| Point72 Asset Management | 60k | $140k | 37% | Mar 2026 |
|
| Invesco | 45k | $106k | 84% | Mar 2026 |
|
| Quadrature Capital | 40k | $94k | 6% | Mar 2026 |
|
| OMERS Administration Corporation | 39k | $92k | -70% | Mar 2026 |
|
| Verdad Advisers | 34k | $78k | 100% | Mar 2026 |
|
| Axxcess Wealth Management | 33k | $72k | 100% | Jun 2026 |
|
| Capital Asset Advisory Services | 33k | $92k | 0% | Mar 2026 |
|
| Simplex Trading | 30k | $71k | -15% | Mar 2026 |
|
| Three Seasons Wealth | 30k | $70k | 0% | Mar 2026 |
|
| Dimensional Fund Advisors | 30k | $70k | 0% | Mar 2026 |
|
| Charles Schwab Investment Management | 29k | $67k | 0% | Mar 2026 |
|
| Vanguard Global Advisers | 25k | $60k | 100% | Mar 2026 |
|
| Schonfeld Strategic Advisors | 20k | $48k | 100% | Mar 2026 |
|
| Citigroup | 19k | $45k | 100% | Mar 2026 |
|
| Assenagon Asset Management | 19k | $41k | 0% | Jun 2026 |
|
| Occudo Quantitative Strategies | 16k | $41k | 100% | Mar 2026 |
|
| Intrepid Family Office | 16k | $38k | -90% | Mar 2026 |
|
| FNY Investment Advisers | 8.3k | $18k | 57% | Jun 2026 |
|
| Jones Financial Companies, L.L | 7.7k | $18k | 19% | Mar 2026 |
|
| Morgan Stanley | 4.6k | $11k | 1354% | Mar 2026 |
|
| UBS Group | 3.0k | $7.0k | -97% | Mar 2026 |
|
| Advisor Group Holdings | 290.00 | $677.991000 | 0% | Mar 2026 |
|
| Wells Fargo & Company | 200.00 | $468.000000 | 0% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 40.00 | $94.000000 | 0% | Mar 2026 |
|
| Farther Finance Advisors | 10.00 | $22.000000 | 0% | Jun 2026 |
|
| SBI Securities | 9.00 | $20.999700 | 0% | Mar 2026 |
|
| Caitong International Asset Management | 3.00 | $6.999900 | 100% | Mar 2026 |
|
Who sold out of Spero Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Eudaimonia Asset Management | Dec 2025 | 218k | $508k |
| Two Sigma Advisers | Dec 2025 | 217k | $505k |
| Sei Investments | Dec 2025 | 132k | $0 |
| ADAR1 Capital Management | Dec 2025 | 114k | $265k |
| None | Dec 2025 | 60k | $141k |
| Millennium Management | Dec 2025 | 24k | $56k |
| Torrey Growth & Income Advisors | Mar 2026 | 17k | $38k |
| XTX Topco | Dec 2025 | 15k | $35k |
| Yale Capital Corp. | Dec 2025 | 10k | $23k |
| Tower Research Capital | Dec 2025 | 7.2k | $17k |
| Rockefeller Capital Management | Dec 2025 | 200.00 | $466.000000 |